Vascular effects of Δ9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta
- 1 January 2005
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 507 (1-3) , 211-221
- https://doi.org/10.1016/j.ejphar.2004.11.056
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ CurrentJournal of Biological Chemistry, 2003
- Endothelium‐independent relaxation to cannabinoids in rat‐isolated mesenteric artery and role of Ca2+ influxBritish Journal of Pharmacology, 2003
- Mechanisms Underlying Tissue Selectivity of Anandamide and Other Vanilloid Receptor AgonistsMolecular Pharmacology, 2002
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivoBiochemical Journal, 2000
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsProceedings of the National Academy of Sciences, 1999
- Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscleBritish Journal of Pharmacology, 1999
- Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant micePublished by Elsevier ,1999
- Inhibition of the production of endothelium‐derived hyperpolarizing factor by cannabinoid receptor agonistsBritish Journal of Pharmacology, 1999
- 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptorsEuropean Journal of Pharmacology, 1996